Docstoc

Teleflex Announces FDA 510(k) Market Clearance of Its ArrowEVOLUTION™ Pressure Injectable Peripherally Inserted Central Catheter with Chlorag+ard™ Technology

Document Sample
Teleflex Announces FDA 510(k) Market Clearance of Its ArrowEVOLUTION™ Pressure Injectable Peripherally Inserted Central Catheter with Chlorag+ard™ Technology Powered By Docstoc
					Teleflex Announces FDA 510(k) Market Clearance
of Its ArrowEVOLUTION™ Pressure Injectable 
Peripherally Inserted Central Catheter with
Chlorag+ard™ Technology
September 07, 2010 09:08 AM Eastern Daylight Time  

LIMERICK, Pa.--(EON: Enhanced Online News)--Teleflex Incorporated (NYSE:TFX) today announced that it
has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company’s
ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a 
Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and
extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

"Market clearance from FDA for the ArrowEVOLUTION PICC with Chlorag+ard technology represents another
significant milestone for Teleflex as we continue to provide innovative technologies to support healthcare providers
who are working to improve patient outcomes through infection prevention,” commented Jeff Black, Teleflex
Chairman and Chief Executive Officer. "We believe the ArrowEVOLUTION PICC with its anti-microbial coating
will provide a technological advancement and unique option to clinicians in their efforts to protect against central line-
associated bloodstream infections, a major contributor to hospital acquired infections.” 

Through its Arrow brand, Teleflex is one of the leading global providers of vascular access technology with a
commitment to helping healthcare providers in their efforts toward attaining and sustaining zero central line-
associated bloodstream infections. The Arrow family of products also includes ARROWg+ard Blue PLUS® acute
central venous catheters with a Chlorhexedine-based technology and Maximal Barrier Precautions Trays designed to
support compliance with practice recommendations and guidelines.

About Teleflex Incorporated

Teleflex Incorporated (NYSE: TFX) is a global provider of medical technology products that enable healthcare
providers to improve patient outcomes, protect against infections and support patient and provider safety. Teleflex,
which employs approximately 12,600 people worldwide, also has niche businesses that serve segments of the
aerospace and commercial markets with specialty engineered products. Additional information about Teleflex can be
obtained from the company's website at www.teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are based on our management’s current beliefs and
expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause
actual results or company actions to differ materially from what is expressed or implied by these statements. These
risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange
Commission, including our Annual Report on Form 10-K.

Contacts
Teleflex Incorporated
Jake Elguicze, 610-948-2836
Vice President, Investor Relations
Permalink: http://eon.businesswire.com/news/eon/20100907005619/en

				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:7
posted:9/7/2010
language:English
pages:2
Description: LIMERICK, Pa.--(EON: Enhanced Online News)--Teleflex Incorporated (NYSE:TFX) today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company’s ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the Unite a styl
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.